Restory: an online, anonymous trauma therapy for adults affected by sexual abuse
Official title: A Randomised Waitlist Controlled Clinical Trial of the Restory Trauma Treatment Program
Run by Karolinska Institutet · NCT07610187 · Data updated 2026-11-12
A free, anonymous online therapy program called Restory tests whether it helps reduce PTSD symptoms in adults who experienced sexual abuse, compared with a waitlist control.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | May 4, 2026 |
| Main results expected | May 4, 2027 |
| Study ends | November 4, 2027 |
| Registry record updated | August 7, 2026 |
| Trial ID | NCT07610187 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older with a history of sexual violence, a PCL-5 score of at least 30, and stable or no psychotropic medication, who can use Swedish and participate remotely.
✕Probably not a fit
Individuals with ongoing acute trauma threats, severe psychiatric conditions requiring immediate care, current trauma-focused therapy, benzodiazepine treatment, or no trauma memory may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Restory is an anonymous internet-based cognitive behavioral therapy program providing prolonged exposure for adults who have experienced sexual abuse. In a pre-registered randomized controlled trial, participants are assigned to either the Restory treatment or a waitlist control to see if PTSD symptom severity (PCL-5) improves more with Restory. The program aims to increase accessibility and reduce barriers to care by offering nationwide, low-threshold treatment that can be used remotely. iCBT has shown promise for PTSD, and Restory seeks to determine its effectiveness specifically for sexual abuse victims in Sweden. The study also notes potential benefits in self-efficacy and engagement through a patient-directed treatment approach.
Why it matters
Potential benefit: If successful, Restory could provide a scalable, accessible option for reducing PTSD symptoms in sexual abuse survivors who face barriers to traditional care.
How similar studies have gone: Previous internet-based PTSD therapies have shown efficacy, though results vary; this trial tests a specific anonymous iCBT prolonged exposure approach for sexual abuse survivors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18+ years * exposure to sexual violence where a minimum of 1 month has passed since the incident * self-reported total PCL-5 of minimum 30 * current stable dose of psychotropic medication (for at least 4 weeks) or medication free * sufficient Swedish skills * willingness and availability to participate Exclusion Criteria: * Ongoing trauma-related threat (e.g. living with a violent spouse) * severe psychiatric illness requiring immediate alternative treatment (such as high acute suicide risk or presence of psychotic episode, assessed during screening interview) * current participation in other trauma-focused CBT or Eye Movement Desensitization and Reprocessing therapy * current benzodiazepine treatment * no trauma memory
Where it's running
-
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet
Stockholm, Sweden Recruiting
Study contacts
- Study coordinator: Malin Joleby, PhD
- Email: malin.joleby@ki.se
- Phone: +46736971237
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
COMP360 psilocybin for PTSD: see if it helps reduce symptoms with guided support
This study tests COMP360 (a lab-made psilocybin) to see if it can help reduce PTSD symptoms in adults, with supervision from a trained team.
-
Virtual Reality–Assisted Trauma-Focused CBT for PTSD
A VR-assisted trauma-focused CBT approach is being tested to see if it helps adults with PTSD related to Northern Ireland–specific trauma.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Predicting nightmare awakenings in PTSD using an AI algorithm
The study tests an AI tool called CAUD-PIN to see if it can reliably predict when trauma-related nightmares will wake military personnel or veterans with PTSD.
-
Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced
This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.